To determine the mechanism underlying the inhibitory effect of JMJD3 on Oct4 in breast cancer cells, we first compared the activity of the Oct4 promoter in stable JMJD3-overexpressing and control cells by a dual luciferase assay. Here, KDM6B is linked to breast cancer.